Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01636661 · ClinicalTrials.gov registry record · Early Phase 1
Safety of Transcranial Direct Current Stimulation in Pediatric Hemiparesis
A Early Phase 1 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 13
- Enrollment target
NCT01636661 is a Early Phase 1 study that has completed, run by University of Minnesota. The registered enrollment target is 13 participants.
The verdict
NCT01636661, a Early Phase 1 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 13 participants
- Enrollment target
Study Summary
The primary objective of this proposal is to investigate the safety of use of transcranial Direct Current Stimulation (tDCS)in children with hemiparesis. The research question, "Is transcranial Direct Current Stimulation safe for use in children with congenital hemiparesis?" relates to two hypotheses: 1. tDCS will not produce a major adverse event, including seizure activity. 2. No change in paretic or nonparetic hand function or cognitive status will occur.
Interventions
- DEVICE tDCS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2012-07 |
| Est. Completion | 2013-12 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01636661
The ClinicalTrials.gov registry entry for NCT01636661 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which tDCS is the first listed.
NCT01636661 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01636661 about?
NCT01636661 is a clinical study titled "Safety of Transcranial Direct Current Stimulation in Pediatric Hemiparesis". The primary objective of this proposal is to investigate the safety of use of transcranial Direct Current Stimulation (tDCS)in children with hemiparesis. The research question, "Is transcranial Direct Current Stimulation safe for use in children with congenital hemiparesis?" relates to two hypothes...
What is the current status of trial NCT01636661?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 13 participants. The study started on 2012-07. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01636661?
The interventions under investigation include: tDCS (DEVICE).
Who is sponsoring clinical trial NCT01636661?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.